Zydus Cadila Enters Vaccines Market by Acquiring Etna Biotech
By Taskin Ahmed
Pharma Deals Review: Vol 2008 Issue 102 (Table of Contents)
Published: 11 Nov-2008
DOI: 10.3833/pdr.v2008.i102.113 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Indian Pharmaceutical company, Zydus Cadila, has stepped into the vaccines market with the acquisition of vaccine developer, Etna Biotech, a subsidiary of Crucell NV of The Netherlands...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS